Susquehanna International Group, LLP Aytu Biopharma, Inc Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.19 - $3.8 $10,713 - $214,278	56,389 New	56,389 $10,000
Q1 2022 May 16, 2022	BUY	$1.08 - $1.55 $27,380 - $39,295	25,352 Added 79.16%	57,380 $62,000
Q4 2021 Feb 14, 2022	SELL	$1.35 - $2.95 $167,863 - $366,811	-124,343 Reduced 79.52%	32,028 $43,000
Q3 2021 Nov 15, 2021	BUY	$2.78 - $5.12 $148,126 - $272,808	53,283 Added 51.69%	156,371 $450,000
Q2 2021 Aug 11, 2021	BUY	$4.73 - $7.56 $266,147 - $425,386	56,268 Added 120.18%	103,088 $516,000
Q1 2021 May 17, 2021	BUY	$6.23 - $9.88 $291,688 - $462,581	46,820 New	46,820 $356,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.